Live Pharmaceutical Import data of Vietnam imports from india under HS Code 29 via Port Cchq-top-managementuh-processing , our Vietnam customs import data reports include date, value, quantity, product description, HS code, port, country, and Vietnam pharmaceutical importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Value($) |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-04-01 00:00:00 |
29163990
|
IBUPROFEN BP2023 (Pharmaceutical ingredients for drug production); 4001/1201/24/A-0381- Production:T02/2024- Expiry:T01/2029 and 4001/1201/24/A-0081; 4001/1201/24/A-0086; 4001/1201/24/A-0090; (*) - Production date: January 2024 - Expiry date: December 202 | India | CCHQ Top ManagementUh processing | 9750 | KGM | 97500 | Importer Name |
| 2024-04-01 00:00:00 |
29332900
|
Pharmaceutical raw materials used for research and testing of VALSARTAN, TC: EP11.0, Lot number: VSV2312033, NSX; December 2023. Expiry date: November 2027. Manufacturer: SMILAX LABORATORIES LIMITED. INDIA | India | CCHQ Top ManagementUh processing | 8 | KGM | 1840 | Importer Name |
| 2024-04-04 00:00:00 |
29252900
|
METFORMIN HYDROCHLORIDE BP2023 (Pharmaceutical substance for drug production); Lot number: 2023MPC0410 (Production: October 2023- Expiry date: September 2028); 2023MPC0519 (Production: December 2023- Expiry date: November 2028) and (*); New 100% | India | CCHQ Top ManagementUh processing | 10000 | KGM | 35000 | Importer Name |
| 2024-04-19 00:00:00 |
29242990
|
LIDOCAINE HYDROCHLORIDE USP-NF-2023 (Pharmaceutical substance for drug production); Lot number: AE240043A; AE240044A; AE240045A ; Production date: February 2024 - Expiry date: January 2029; New 100%, | India | CCHQ Top ManagementUh processing | 1000 | KGM | 11500 | Importer Name |
2024-04-01 00:00:00
IBUPROFEN BP2023 (Pharmaceutical ingredients for drug production); 4001/1201/24/A-0381- Production:T02/2024- Expiry:T01/2029 and 4001/1201/24/A-0081; 4001/1201/24/A-0086; 4001/1201/24/A-0090; (*) - Production date: January 2024 - Expiry date: December 202
9750
KGM
97500
2024-04-01 00:00:00
Pharmaceutical raw materials used for research and testing of VALSARTAN, TC: EP11.0, Lot number: VSV2312033, NSX; December 2023. Expiry date: November 2027. Manufacturer: SMILAX LABORATORIES LIMITED. INDIA
8
KGM
1840
2024-04-04 00:00:00
METFORMIN HYDROCHLORIDE BP2023 (Pharmaceutical substance for drug production); Lot number: 2023MPC0410 (Production: October 2023- Expiry date: September 2028); 2023MPC0519 (Production: December 2023- Expiry date: November 2028) and (*); New 100%
10000
KGM
35000
2024-04-19 00:00:00
LIDOCAINE HYDROCHLORIDE USP-NF-2023 (Pharmaceutical substance for drug production); Lot number: AE240043A; AE240044A; AE240045A ; Production date: February 2024 - Expiry date: January 2029; New 100%,
1000
KGM
11500
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 29 for Vietnam pharmaceutical imports from Thailand via Port Cchq-top-managementuh-processing.
Port Cchq-top-managementuh-processing typically refers to a port that is used for handling and forwarding shipments into Vietnam, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharmaceutical products, enabling better decision-making for trade and market expansion for Vietnam pharmaceutical imports from india under HS code 29 via Port Cchq-top-managementuh-processing.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharmaceutical market.
